Nicholson JK, Lindon JC. Systems biology: metabonomics. Nature. 2008;455(7216):1054–6. https://doi.org/10.1038/4551054a.

Article  CAS  PubMed  Google Scholar 

Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372(9):793–5. https://doi.org/10.1056/NEJMp1500523.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beger RD, Dunn W, Schmidt MA, et al. Metabolomics enables precision medicine: “a white paper, community perspective.” Metabolomics. 2016;12(9):149. https://doi.org/10.1007/s11306-016-1094-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cruz DE, Tahir UA, Hu J, et al. Metabolomic analysis of coronary heart disease in an African American cohort from the Jackson Heart Study. JAMA Cardiol. 2022;7(2):184–94. https://doi.org/10.1001/jamacardio.2021.4925.

Article  PubMed  Google Scholar 

Li J, Guasch-Ferré M, Chung W, et al. The mediterranean diet, plasma metabolome, and cardiovascular disease risk. Eur Heart J. 2020;41(28):2645–56. https://doi.org/10.1093/eurheartj/ehaa209.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cavus E, Karakas M, Ojeda FM, et al. Association of circulating metabolites with risk of coronary heart disease in a European population: results from the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium. JAMA Cardiol. 2019;4(12):1270–9. https://doi.org/10.1001/jamacardio.2019.4130.

Article  PubMed  PubMed Central  Google Scholar 

Paynter NP, Balasubramanian R, Giulianini F, et al. Metabolic predictors of incident coronary heart disease in women. Circulation. 2018;137(8):841–53. https://doi.org/10.1161/CIRCULATIONAHA.117.029468.

Article  PubMed  PubMed Central  Google Scholar 

Ruiz-Canela M, Hruby A, Clish CB, Liang L, Martínez-González MA, Hu FB. Comprehensive metabolomic profiling and incident cardiovascular disease: a systematic review. J Am Heart Assoc. 2017. https://doi.org/10.1161/JAHA.117.005705.

Article  PubMed  PubMed Central  Google Scholar 

Würtz P, Havulinna AS, Soininen P, et al. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation. 2015;131(9):774–85. https://doi.org/10.1161/CIRCULATIONAHA.114.013116.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeleznik OA, Clish CB, Kraft P, Avila-Pacheco J, Eliassen AH, Tworoger SS. Circulating lysophosphatidylcholines, phosphatidylcholines, ceramides, and sphingomyelins and ovarian cancer risk: a 23-year prospective study. J Natl Cancer Inst. 2019;112(6):628–36. https://doi.org/10.1093/jnci/djz195.

Article  CAS  PubMed Central  Google Scholar 

Moore SC, Playdon MC, Sampson JN, et al. A metabolomics analysis of body mass index and postmenopausal breast cancer risk. J Natl Cancer Inst. 2018;110(6):588–97. https://doi.org/10.1093/jnci/djx244.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kühn T, Floegel A, Sookthai D, et al. Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study. BMC Med. 2016;14:13. https://doi.org/10.1186/s12916-016-0552-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang J, Mondul AM, Weinstein SJ, et al. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Br J Cancer. 2016;115(9):1087–95. https://doi.org/10.1038/bjc.2016.305.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mondul AM, Moore SC, Weinstein SJ, Karoly ED, Sampson JN, Albanes D. Metabolomic analysis of prostate cancer risk in a prospective cohort: the alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study. Int J Cancer. 2015;137(9):2124–32. https://doi.org/10.1002/ijc.29576.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mayers JR, Wu C, Clish CB, et al. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med. 2014;20(10):1193–8. https://doi.org/10.1038/nm.3686.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guasch-Ferré M, Hruby A, Toledo E, et al. Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes Care. 2016;39(5):833–46. https://doi.org/10.2337/dc15-2251.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu D, Moore SC, Matthews CE, et al. Plasma metabolomic profiles in association with type 2 diabetes risk and prevalence in Chinese adults. Metabolomics. 2015;12(1):3. https://doi.org/10.1007/s11306-015-0890-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Menni C, Fauman E, Erte I, et al. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes. 2013;62(12):4270–6. https://doi.org/10.2337/db13-0570.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Floegel A, Stefan N, Yu Z, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013;62(2):639–48. https://doi.org/10.2337/db12-0495.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17(4):448–53. https://doi.org/10.1038/nm.2307.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang T, Balasubramanian R, Yao Y, et al. Associations of depression status with plasma levels of candidate lipid and amino acid metabolites: a meta-analysis of individual data from three independent samples of US postmenopausal women. Molecular Psychiatry. 2020. https://doi.org/10.1038/s41380-020-00870-9.

Article  PubMed  PubMed Central  Google Scholar 

Liu X, Zheng P, Zhao X, et al. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry. J Proteome Res. 2015;14(5):2322–30. https://doi.org/10.1021/acs.jproteome.5b00144.

Article  CAS  PubMed  Google Scholar 

Balasubramanian R, Paynter NP, Giulianini F, et al. Metabolomic profiles associated with all-cause mortality in the Women’s Health Initiative. Int J Epidemiol. 2020;49(1):289–300. https://doi.org/10.1093/ije/dyz211.

Article  PubMed  Google Scholar 

Deelen J, Kettunen J, Fischer K, et al. A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals. Nat Commun. 2019;10(1):3346. https://doi.org/10.1038/s41467-019-11311-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu B, Heiss G, Alexander D, Grams ME, Boerwinkle E. Associations between the serum metabolome and all-cause mortality among African Americans in the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol. 2016;183(7):650–6. https://doi.org/10.1093/aje/kwv213.

Article  PubMed  PubMed Central  Google Scholar 

Cheng S, Larson MG, McCabe EL, et al. Distinct metabolomic signatures are associated with longevity in humans. Nat Commun. 2015;6:6791. https://doi.org/10.1038/ncomms7791.

Article